EU Reaches Landmark Agreement on “New GMOs” Amid Environmental Concerns

European regulators have reached a provisional agreement on plants produced using new genomic techniques (NGTs), sparking intense debate between agricultural innovators and environmental activists. The agreement, finalized during the night of December 3-4, would simplify procedures for certain genetically modified plants when definitively adopted in March 2026.

The European Commission’s proposal, initially presented in July 2023, aims to exempt plants produced using advanced genetic engineering methods such as CRISPR-Cas9 from existing GMO regulations, which effectively prohibit GMO cultivation across most of the EU. The stated goal is maintaining “a high level of health and environmental protection” while addressing competitiveness concerns.

Four prominent environmentalists—MPs Lisa Belluci and Benoît Biteau, former MEP José Bové, and current MEP Marie Toussaint—published an opinion piece in Le Monde warning of dire consequences if the agreement is implemented. They described the deal as “nothing too good to ensure the profits of seed companies and pesticide manufacturers” and raised alarms about “patenting of life forms” and “irreversible contamination” of genetic resources.

Their concerns primarily center on intellectual property issues. They argue that allowing patents on NGT-derived plants would enable large corporations like Corteva, Bayer, and Limagrain to “lock down access to genetic resources and impose costly licenses that small businesses cannot afford,” potentially driving smaller seed producers out of the market.

However, EU Directive 98/44/EC already addresses such concerns through a system of compulsory cross-licensing, which ensures breeders can still access patented technologies for a reasonable fee. Additionally, farmers’ rights regarding farm-saved seeds are protected under existing EU regulations.

The environmentalists’ fears of “irreversible contamination” of local and ancient genetic resources appear exaggerated when examined against standard agricultural practices. Seed producers routinely implement isolation measures to maintain varietal purity, and the mechanisms for containing NGT varieties would be no different than those used for conventional crops.

The agreement specifically excludes herbicide-tolerant varieties from the simplified approval procedure, addressing one of the main criticisms leveled at traditional GMOs. Proponents argue that NGTs offer powerful tools for developing pest and disease resistance, potentially reducing pesticide use rather than increasing it.

The compromise text was adopted by the EU Council on December 19, with France voting in favor while Germany abstained. Austria, Bulgaria, Croatia, Hungary, Romania, Slovakia, and Slovenia voted against the measure. In total, eighteen states supported the agreement, representing 66.17% of the EU population—just above the 65% threshold required.

The European Parliament must still approve the text before it becomes law, likely in spring 2026.

Critics view the regulation as undermining the 2018 Court of Justice of the European Union ruling, which determined that organisms obtained through mutagenesis techniques should be regulated as GMOs. However, supporters note that parliamentary action to amend existing law is precisely what the current regulatory process entails.

The debate highlights the tension between embracing agricultural innovation and addressing environmental concerns, with significant implications for European farming, food security, and competitiveness in global biotechnology markets. The final parliamentary vote will determine whether Europe shifts toward a more permissive approach to these new plant breeding technologies or maintains its traditionally cautious stance on genetic modification.